Trading in Ascelia Pharma’s shares on Nasdaq Stockholm commences tomorrow
Nasdaq Stockholm AB has today decided to admit the shares of Ascelia Pharma AB (“Ascelia Pharma” or the “Company”) for trading on Nasdaq Stockholm with first day of trading tomorrow, Wednesday 13 March 2019.
The shares will be traded under the ticker ACE and ISIN SE0010573113. The offering in Ascelia Pharma AB in connection with the listing on Nasdaq Stockholm was, as previously communicated, significantly oversubscribed. The offering provided Ascelia Pharma with approximately SEK 200 million before deductions for expenses related to the offering.
Press inquiries should be adressed to: